Stool DNA methylation assays in colorectal cancer screening
Authors:
Open Access
- 21 September 2015
- journal article
- editorial
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 21 (35) , 10057-10061
Abstract
Colorectal cancer (CRC) is fourth most common cancer in men and third in women worldwide. Developing a diagnostic panel of sensitive and specific biomarkers for the early detection of CRC is recognised as to be crucial for early initial diagnosis, which in turn leads to better long term survival. Most of the research on novel potential CRC biomarkers in the last 2 decades has been focussed on stool DNA analysis. In this paper, we describe the recent advances in non-invasive CRC screening and more specifically in molecular assays for aberrantly methylated BMP3 and NDRG4 promoter regions. In several research papers these markers showed superior rates for sensitivity and specificity in comparison to previously described assays. These tests detected the majority of adenomas ≥ 1 cm in size and the detection rates progressively increased with larger adenomas. The methylation status of the BMP3 and NDRG4 promoters demonstrated effective detection of neoplasms at all sites throughout the colon and was not affected by common clinical variables. Recently, a multitarget stool DNA test consisting of molecular assays for aberrantly methylated BMP3 and NDRG4 promoter regions, mutant KRAS and immunochemical assay for human haemoglobin has been made commercially available and is currently reimbursed in the United States. Although this is the most sensitive non-invasive CRC screening test, there is the need for further research in several areas - establishment of the best timeframe for repeated DNA stool testing; validation of the results in populations outside of North America; usefulness for surveillance and prognosis of patients; cost-effectiveness of DNA stool testing in real-life populations.Keywords
This publication has 28 references indexed in Scilit:
- Next-Generation Stool DNA Test Accurately Detects Colorectal Cancer and Large AdenomasGastroenterology, 2012
- Patients’ experiences and reported barriers to colonoscopy in the screening context—A systematic review of the literaturePatient Education and Counseling, 2012
- Screening for colorectal cancer: established and emerging modalitiesNature Reviews Gastroenterology & Hepatology, 2011
- Cost-effectiveness of Colorectal Cancer ScreeningEpidemiologic Reviews, 2011
- Use of faecal markers in screening for colorectal neoplasia: a European group on tumor markers position paperInternational Journal of Cancer, 2010
- Worldwide Variations in Colorectal CancerCA: A Cancer Journal for Clinicians, 2009
- N-Myc Downstream-Regulated Gene 4 ( NDRG4 ): A Candidate Tumor Suppressor Gene and Potential Biomarker for Colorectal CancerJNCI: Journal of the National Cancer Institute, 2009
- Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous Polyps, 2008: A Joint Guideline From the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of RadiologyGastroenterology, 2008
- Bone morphogenic protein 3 inactivation is an early and frequent event in colorectal cancer developmentGenes, Chromosomes and Cancer, 2008
- Fecal DNA versus Fecal Occult Blood for Colorectal-Cancer Screening in an Average-Risk PopulationNew England Journal of Medicine, 2004